Showing results (151-160 of 186) with videos related to
Sort By:
Pageof 19
Cancer|January 15, 1990
Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trialD C Tormey, R Gray, K Gilchrist, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 31, 1998
Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithineP P Carbone, J A Douglas, P O Larson, et al.Journal of the National Cancer Institute|May 5, 1993
Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithineR R Love, P P Carbone, A K Verma, et al.Cancer Research|May 1, 1990
Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusionS C Remick, J L Grem, P H Fischer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinomaJ L Grem, E Jordan, M E Robson, et al.Cancer Treatment Reports|September 1, 1978
Phase II study of adriamycin and bleomycin in patients with multiple myelomaJ M Bennett, R Silber, E Ezdinli, et al.Journal of the National Cancer Institute|August 15, 1990
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancerR R Love, P A Newcomb, D A Wiebe, et al.Cancer Treatment Reports|July 1, 1978
Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancerR G Hahn, N R Temkin, E D Savlov, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Aggressive combined modality therapy for advanced local-regional breast carcinomaC L Loprinzi, P P Carbone, D C Tormey, et al.Cancer|February 1, 1979
Eastern Cooperative Oncology Group experience with the rappaport classification of non-Hodgkin's lymphomasE Z Ezdinli, W Costello, L P Wasser, et al.Pageof 19